Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2009

01-10-2009 | Research Article

An evaluation of the integration of standards and guidelines in community pharmacy practices

Authors: H. Laetitia Hattingh, Michelle A. King, Nerida A. Smith

Published in: International Journal of Clinical Pharmacy | Issue 5/2009

Login to get access

Abstract

Objective To explore the usefulness and implementation of practice standards in community pharmacy practice regarding contemporary core services. Setting Community pharmacies in South East Queensland, Australia. Method During August and September 2006 semi-structured interviews with community pharmacists explored practice processes and procedures and the utilisation of endorsed standards and guidelines. Thematic content analysis of the interviews, inductive analysis and continual comparison of categories and concepts enabled common and distinct themes to be clarified. Main outcome measure Usefulness and integration of practice standards in the provision of core pharmacy services, utilisation of support staff, record keeping and overall risk management processes in community pharmacy. Results Seventeen community pharmacists participated, representing a wide range of demographics, experience and pharmacy types. Staff utilisation and record keeping practices were analysed as well as two core services, namely: (1) the supply of over-the-counter medicines, and (2) the dispensing of prescriptions. The procedures followed concerning the supply of over-the-counter medicines varied. The majority of participants did not regard this as a pharmacist’s immediate role, but rather relied on support staff to identify when the supply required a pharmacist’s intervention. Whilst all participants involved dispensary assistants in the dispensing process, the delegation of procedures differed. Most participants did not clearly differentiate between pharmacists’ and dispensary assistants’ activities. Dispensing processes and the involvement of pharmacists in the provision of patient advice varied. Pharmacist intervention record keeping was uncommon and records of ‘near misses’ were not routinely kept by any of the participants. Conclusion A lack of integration of practice standards indicated a need to review the standards for relevance. Additionally, pharmacists need to re-evaluate workflow models and the delegation of tasks in the light of new roles and responsibilities.
Literature
1.
2.
go back to reference Albrecht L, Roberts A, Benrimoj C, Williams K, Chen T, Asani P. Cognitive pharmaceutical services: financial facilitators. Aust Pharm. 2006;25:809–15. Albrecht L, Roberts A, Benrimoj C, Williams K, Chen T, Asani P. Cognitive pharmaceutical services: financial facilitators. Aust Pharm. 2006;25:809–15.
3.
go back to reference Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills CR. Enhanced pharmacy services, barriers and facilitators in Australia’ community pharmacies: Australia’s National Pharmacy Database Project. Int J Pharm Pract. 2007;15:185–91. doi:10.1211/ijpp.15.3.0005.CrossRef Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills CR. Enhanced pharmacy services, barriers and facilitators in Australia’ community pharmacies: Australia’s National Pharmacy Database Project. Int J Pharm Pract. 2007;15:185–91. doi:10.​1211/​ijpp.​15.​3.​0005.CrossRef
4.
go back to reference Niselle P. Managing medical indemnity: must we choose between quality assurance and risk management? Med J Aust. 2004;181:64–5. Niselle P. Managing medical indemnity: must we choose between quality assurance and risk management? Med J Aust. 2004;181:64–5.
5.
go back to reference Donabedian A. Medical care appraisal—quality and utilisation. Washington DC: American Public Health Association; 1969. p. 2. Donabedian A. Medical care appraisal—quality and utilisation. Washington DC: American Public Health Association; 1969. p. 2.
6.
go back to reference Standards Association of Australia. Australian/New Zealand Standard—risk management: AS/NZS 4360. Homebush, NSW: Standards Australia International Limited; 2004. Standards Association of Australia. Australian/New Zealand Standard—risk management: AS/NZS 4360. Homebush, NSW: Standards Australia International Limited; 2004.
7.
go back to reference Standards Association of Australia. Australian/New Zealand Standard—handbook: risk management guidelines: companion to AS/NZS 4360. Homebush, NSW: Standards Australia International Limited; 2004. Standards Association of Australia. Australian/New Zealand Standard—handbook: risk management guidelines: companion to AS/NZS 4360. Homebush, NSW: Standards Australia International Limited; 2004.
8.
go back to reference Hattingh HL, Smith NA, Searle J, King MA, Forrester K. Regulation of the pharmacy profession throughout Australia. J Pharm Pract Res. 2007;37:174–7.CrossRef Hattingh HL, Smith NA, Searle J, King MA, Forrester K. Regulation of the pharmacy profession throughout Australia. J Pharm Pract Res. 2007;37:174–7.CrossRef
10.
go back to reference Pharmaceutical Society of Australia. Australian pharmaceutical formulary and handbook. 20th ed. Canberra: Pharmaceutical Society of Australia; 2006. p. 445–97. Pharmaceutical Society of Australia. Australian pharmaceutical formulary and handbook. 20th ed. Canberra: Pharmaceutical Society of Australia; 2006. p. 445–97.
11.
go back to reference Newgreen DB, Pressley JA, Marty SH. A survey of dispensing errors reported to the Pharmacy Board of Victoria, July 1998 to December 2004. Aust Pharm. 2005;24:644–8. Newgreen DB, Pressley JA, Marty SH. A survey of dispensing errors reported to the Pharmacy Board of Victoria, July 1998 to December 2004. Aust Pharm. 2005;24:644–8.
13.
go back to reference Pharmaceutical Society of Australia. Professional practice standards. 3rd ed. Curtin: Pharmaceutical Society of Australia; 2006. p. 43–9. Pharmaceutical Society of Australia. Professional practice standards. 3rd ed. Curtin: Pharmaceutical Society of Australia; 2006. p. 43–9.
16.
go back to reference Kinrade W. Workforce and career options for pharmacy assistants (Report). Collingwood, Victoria: Healthcare Management Advisors; December 2004. Kinrade W. Workforce and career options for pharmacy assistants (Report). Collingwood, Victoria: Healthcare Management Advisors; December 2004.
18.
go back to reference Hattingh L, Forrester K, Smith N, Searle J. Pharmacy practice developments: the potential impact on pharmacists’ legal liability. J Law Med. 2007;14:297–402. Hattingh L, Forrester K, Smith N, Searle J. Pharmacy practice developments: the potential impact on pharmacists’ legal liability. J Law Med. 2007;14:297–402.
19.
go back to reference Hattingh HL. An investigation of community pharmacy risk management regulation and practices in the context of an expanding role (Dissertation). Gold Coast, Australia: H.L.Hattingh; 2007. Hattingh HL. An investigation of community pharmacy risk management regulation and practices in the context of an expanding role (Dissertation). Gold Coast, Australia: H.L.Hattingh; 2007.
20.
go back to reference Pharmaceutical Society of Australia. Standards for the provision of pharmacy medicines and pharmacist only medicines in community pharmacy. 2nd ed. Curtin: Pharmaceutical Society of Australia; 2005. Pharmaceutical Society of Australia. Standards for the provision of pharmacy medicines and pharmacist only medicines in community pharmacy. 2nd ed. Curtin: Pharmaceutical Society of Australia; 2005.
21.
go back to reference Smith A, McLachlan A. Generic medicines: same difference? National Prescribing Service; 2006, February: 1–4. Smith A, McLachlan A. Generic medicines: same difference? National Prescribing Service; 2006, February: 1–4.
23.
go back to reference Merriam SB. Qualitative research in practice: examples for discussion and analysis. San Francisco: Jossey-Bass; 2002. Merriam SB. Qualitative research in practice: examples for discussion and analysis. San Francisco: Jossey-Bass; 2002.
24.
go back to reference Patton MQ. Qualitative research & evaluation methods. 3rd ed. London: Sage; 2002. p. 125. ISBN 0-7619-1971-6. Patton MQ. Qualitative research & evaluation methods. 3rd ed. London: Sage; 2002. p. 125. ISBN 0-7619-1971-6.
25.
go back to reference Galbally R. Final report of the review of drugs, poisons and controlled substances legislation (Report). Woden, ACT: Secretariat, Review of Drugs, Poisons and Controlled Substances Legislation; 2001. Galbally R. Final report of the review of drugs, poisons and controlled substances legislation (Report). Woden, ACT: Secretariat, Review of Drugs, Poisons and Controlled Substances Legislation; 2001.
26.
go back to reference Strand L. Building a practice in pharmaceutical care. Pharm J. 1998;260:874–6. Strand L. Building a practice in pharmaceutical care. Pharm J. 1998;260:874–6.
28.
go back to reference Gross Z. Benefits of recording interventions. Pharm J. 2001;267:188. Gross Z. Benefits of recording interventions. Pharm J. 2001;267:188.
29.
Metadata
Title
An evaluation of the integration of standards and guidelines in community pharmacy practices
Authors
H. Laetitia Hattingh
Michelle A. King
Nerida A. Smith
Publication date
01-10-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9309-9

Other articles of this Issue 5/2009

International Journal of Clinical Pharmacy 5/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine